| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Familial Mediterranean Fever | D010505 | 12 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Adenomatous Polyposis Coli | D011125 | 16 associated lipids |
29623-28-7
29623-28-7 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1002 references associated with 29623-28-7 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 29623-28-7
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 29623-28-7
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 29623-28-7
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Buchanan MR et al. | 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. | 1985 | J. Biol. Chem. | pmid:3934168 |
| Ek-Von Mentzer BA et al. | Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. implications for transmembrane and intracellular transport and for protection from lipid peroxidation. | 2001 | J. Biol. Chem. | pmid:11278949 |
| Hsi LC et al. | 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. | 2001 | J. Biol. Chem. | pmid:11447213 |
| Kim YS et al. | The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-kappa b in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7. | 2001 | J. Biol. Chem. | pmid:11448950 |
| Cimen I et al. | 15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma. | 2011 | J. Cell. Biochem. | pmid:21544861 |
| Dandona P et al. | The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11232024 |
| Aljada A et al. | Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? | 2001 | J. Clin. Endocrinol. Metab. | pmid:11443197 |
| Schild RL et al. | The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids. | 2002 | J. Clin. Endocrinol. Metab. | pmid:11889173 |
| Aljada A et al. | Troglitazone reduces the expression of PPARgamma while stimulating that of PPARalpha in mononuclear cells in obese subjects. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11443177 |
| Han KH et al. | Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. | 2000 | J. Clin. Invest. | pmid:10995790 |
| Folcik VA et al. | Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. | 1995 | J. Clin. Invest. | pmid:7615823 |
| Kühn H et al. | In vivo action of 15-lipoxygenase in early stages of human atherogenesis. | 1997 | J. Clin. Invest. | pmid:9062346 |
| Ikawa H et al. | Arachidonate 12-lipoxygenase in porcine anterior pituitary cells: its localization and possible function in gonadotrophs. | 1996 | J. Endocrinol. | pmid:8568469 |
| Kühn H et al. | Involvement of 15-lipoxygenase in early stages of atherogenesis. | 1994 | J. Exp. Med. | pmid:8195716 |
| Yoshinaga M et al. | The 15-lipoxygenase-1 expression may enhance the sensitivity to non-steroidal anti-inflammatory drug-induced apoptosis in colorectal cancers from patients who are treated with the compounds. | 2007 | J. Gastroenterol. Hepatol. | pmid:17559385 |
| Matzner Y et al. | Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells. | 1988 | J. Immunol. | pmid:3128604 |
| Black LL et al. | Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. | 2015 | J. Immunol. | pmid:26466956 |
| Fischer B et al. | Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma. | 2002 | J. Immunol. | pmid:11884452 |
| Coutant F et al. | Sensing environmental lipids by dendritic cell modulates its function. | 2004 | J. Immunol. | pmid:14688309 |
| Ogawa E et al. | Epidermal FABP (FABP5) regulates keratinocyte differentiation by 13(S)-HODE-mediated activation of the NF-κB signaling pathway. | 2011 | J. Invest. Dermatol. | pmid:21068754 |